0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-Emetic Drug Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-17B7962
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti Emetic Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Global Anti-Emetic Drug Market Research Report 2024

Code: QYRE-Auto-17B7962
Report
June 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-Emetic Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Anti-Emetic Drug Market

Anti-Emetic Drug Market

Anti-emetic drugs are drugs that prevent or reduce nausea and vomiting. Antiemetic drugs inhibit vomiting reactions through different links, including thiazide drugs, antihistamines, and anticholinergics.
The global Anti-Emetic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-Emetic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Emetic Drug.

Report Scope

The Anti-Emetic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Emetic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Emetic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anti-Emetic Drug Market Report

Report Metric Details
Report Name Anti-Emetic Drug Market
CAGR 5%
Segment by Type
  • Oral
  • Injection
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Home Care
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Novartis, Glenmark Pharmaceuticals, F. Hoffmann-La Roche, Heron Therapeutics, Kyowa Kirin, Aurobindo Pharma, Mylan, Hikma, Akorn, Dr. Reddy’s Laboratories, Cipla, Fresenius Kabi, Wockhardt, Sun Pharmaceutical Industries, Teva Pharmaceutical, Pfizer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti-Emetic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti-Emetic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-Emetic Drug Market report?

Ans: The main players in the Anti-Emetic Drug Market are Merck, Novartis, Glenmark Pharmaceuticals, F. Hoffmann-La Roche, Heron Therapeutics, Kyowa Kirin, Aurobindo Pharma, Mylan, Hikma, Akorn, Dr. Reddy’s Laboratories, Cipla, Fresenius Kabi, Wockhardt, Sun Pharmaceutical Industries, Teva Pharmaceutical, Pfizer

What are the Application segmentation covered in the Anti-Emetic Drug Market report?

Ans: The Applications covered in the Anti-Emetic Drug Market report are Hospital, Clinic, Home Care, Others

What are the Type segmentation covered in the Anti-Emetic Drug Market report?

Ans: The Types covered in the Anti-Emetic Drug Market report are Oral, Injection, Others

1 Anti-Emetic Drug Market Overview
1.1 Product Overview and Scope of Anti-Emetic Drug
1.2 Anti-Emetic Drug Segment by Type
1.2.1 Global Anti-Emetic Drug Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Anti-Emetic Drug Segment by Application
1.3.1 Global Anti-Emetic Drug Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Global Anti-Emetic Drug Market Size Estimates and Forecasts
1.4.1 Global Anti-Emetic Drug Revenue 2019-2030
1.4.2 Global Anti-Emetic Drug Sales 2019-2030
1.4.3 Global Anti-Emetic Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-Emetic Drug Market Competition by Manufacturers
2.1 Global Anti-Emetic Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-Emetic Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-Emetic Drug Average Price by Manufacturers (2019-2024)
2.4 Global Anti-Emetic Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Emetic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Emetic Drug, Product Type & Application
2.7 Anti-Emetic Drug Market Competitive Situation and Trends
2.7.1 Anti-Emetic Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Emetic Drug Players Market Share by Revenue
2.7.3 Global Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Emetic Drug Retrospective Market Scenario by Region
3.1 Global Anti-Emetic Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-Emetic Drug Global Anti-Emetic Drug Sales by Region: 2019-2030
3.2.1 Global Anti-Emetic Drug Sales by Region: 2019-2024
3.2.2 Global Anti-Emetic Drug Sales by Region: 2025-2030
3.3 Global Anti-Emetic Drug Global Anti-Emetic Drug Revenue by Region: 2019-2030
3.3.1 Global Anti-Emetic Drug Revenue by Region: 2019-2024
3.3.2 Global Anti-Emetic Drug Revenue by Region: 2025-2030
3.4 North America Anti-Emetic Drug Market Facts & Figures by Country
3.4.1 North America Anti-Emetic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-Emetic Drug Sales by Country (2019-2030)
3.4.3 North America Anti-Emetic Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Emetic Drug Market Facts & Figures by Country
3.5.1 Europe Anti-Emetic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-Emetic Drug Sales by Country (2019-2030)
3.5.3 Europe Anti-Emetic Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Emetic Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Emetic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-Emetic Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-Emetic Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Emetic Drug Market Facts & Figures by Country
3.7.1 Latin America Anti-Emetic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-Emetic Drug Sales by Country (2019-2030)
3.7.3 Latin America Anti-Emetic Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Emetic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Emetic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-Emetic Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-Emetic Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Emetic Drug Sales by Type (2019-2030)
4.1.1 Global Anti-Emetic Drug Sales by Type (2019-2024)
4.1.2 Global Anti-Emetic Drug Sales by Type (2025-2030)
4.1.3 Global Anti-Emetic Drug Sales Market Share by Type (2019-2030)
4.2 Global Anti-Emetic Drug Revenue by Type (2019-2030)
4.2.1 Global Anti-Emetic Drug Revenue by Type (2019-2024)
4.2.2 Global Anti-Emetic Drug Revenue by Type (2025-2030)
4.2.3 Global Anti-Emetic Drug Revenue Market Share by Type (2019-2030)
4.3 Global Anti-Emetic Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-Emetic Drug Sales by Application (2019-2030)
5.1.1 Global Anti-Emetic Drug Sales by Application (2019-2024)
5.1.2 Global Anti-Emetic Drug Sales by Application (2025-2030)
5.1.3 Global Anti-Emetic Drug Sales Market Share by Application (2019-2030)
5.2 Global Anti-Emetic Drug Revenue by Application (2019-2030)
5.2.1 Global Anti-Emetic Drug Revenue by Application (2019-2024)
5.2.2 Global Anti-Emetic Drug Revenue by Application (2025-2030)
5.2.3 Global Anti-Emetic Drug Revenue Market Share by Application (2019-2030)
5.3 Global Anti-Emetic Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Anti-Emetic Drug Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Anti-Emetic Drug Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Glenmark Pharmaceuticals
6.3.1 Glenmark Pharmaceuticals Corporation Information
6.3.2 Glenmark Pharmaceuticals Description and Business Overview
6.3.3 Glenmark Pharmaceuticals Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glenmark Pharmaceuticals Anti-Emetic Drug Product Portfolio
6.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Corporation Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 F. Hoffmann-La Roche Anti-Emetic Drug Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
6.5 Heron Therapeutics
6.5.1 Heron Therapeutics Corporation Information
6.5.2 Heron Therapeutics Description and Business Overview
6.5.3 Heron Therapeutics Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Heron Therapeutics Anti-Emetic Drug Product Portfolio
6.5.5 Heron Therapeutics Recent Developments/Updates
6.6 Kyowa Kirin
6.6.1 Kyowa Kirin Corporation Information
6.6.2 Kyowa Kirin Description and Business Overview
6.6.3 Kyowa Kirin Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kyowa Kirin Anti-Emetic Drug Product Portfolio
6.6.5 Kyowa Kirin Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Anti-Emetic Drug Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Anti-Emetic Drug Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Hikma
6.9.1 Hikma Corporation Information
6.9.2 Hikma Description and Business Overview
6.9.3 Hikma Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hikma Anti-Emetic Drug Product Portfolio
6.9.5 Hikma Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Akorn Anti-Emetic Drug Product Portfolio
6.10.5 Akorn Recent Developments/Updates
6.11 Dr. Reddy’s Laboratories
6.11.1 Dr. Reddy’s Laboratories Corporation Information
6.11.2 Dr. Reddy’s Laboratories Anti-Emetic Drug Description and Business Overview
6.11.3 Dr. Reddy’s Laboratories Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Dr. Reddy’s Laboratories Anti-Emetic Drug Product Portfolio
6.11.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.12 Cipla
6.12.1 Cipla Corporation Information
6.12.2 Cipla Anti-Emetic Drug Description and Business Overview
6.12.3 Cipla Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Cipla Anti-Emetic Drug Product Portfolio
6.12.5 Cipla Recent Developments/Updates
6.13 Fresenius Kabi
6.13.1 Fresenius Kabi Corporation Information
6.13.2 Fresenius Kabi Anti-Emetic Drug Description and Business Overview
6.13.3 Fresenius Kabi Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Fresenius Kabi Anti-Emetic Drug Product Portfolio
6.13.5 Fresenius Kabi Recent Developments/Updates
6.14 Wockhardt
6.14.1 Wockhardt Corporation Information
6.14.2 Wockhardt Anti-Emetic Drug Description and Business Overview
6.14.3 Wockhardt Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Wockhardt Anti-Emetic Drug Product Portfolio
6.14.5 Wockhardt Recent Developments/Updates
6.15 Sun Pharmaceutical Industries
6.15.1 Sun Pharmaceutical Industries Corporation Information
6.15.2 Sun Pharmaceutical Industries Anti-Emetic Drug Description and Business Overview
6.15.3 Sun Pharmaceutical Industries Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sun Pharmaceutical Industries Anti-Emetic Drug Product Portfolio
6.15.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.16 Teva Pharmaceutical
6.16.1 Teva Pharmaceutical Corporation Information
6.16.2 Teva Pharmaceutical Anti-Emetic Drug Description and Business Overview
6.16.3 Teva Pharmaceutical Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Teva Pharmaceutical Anti-Emetic Drug Product Portfolio
6.16.5 Teva Pharmaceutical Recent Developments/Updates
6.17 Pfizer
6.17.1 Pfizer Corporation Information
6.17.2 Pfizer Anti-Emetic Drug Description and Business Overview
6.17.3 Pfizer Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Pfizer Anti-Emetic Drug Product Portfolio
6.17.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Emetic Drug Industry Chain Analysis
7.2 Anti-Emetic Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Emetic Drug Production Mode & Process
7.4 Anti-Emetic Drug Sales and Marketing
7.4.1 Anti-Emetic Drug Sales Channels
7.4.2 Anti-Emetic Drug Distributors
7.5 Anti-Emetic Drug Customers
8 Anti-Emetic Drug Market Dynamics
8.1 Anti-Emetic Drug Industry Trends
8.2 Anti-Emetic Drug Market Drivers
8.3 Anti-Emetic Drug Market Challenges
8.4 Anti-Emetic Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Anti-Emetic Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Anti-Emetic Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Anti-Emetic Drug Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Anti-Emetic Drug Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Anti-Emetic Drug Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Anti-Emetic Drug Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Anti-Emetic Drug Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Anti-Emetic Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Anti-Emetic Drug, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Anti-Emetic Drug, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Anti-Emetic Drug, Product Type & Application
    Table 12. Global Key Manufacturers of Anti-Emetic Drug, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Anti-Emetic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Emetic Drug as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Anti-Emetic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Anti-Emetic Drug Sales by Region (2019-2024) & (K Units)
    Table 18. Global Anti-Emetic Drug Sales Market Share by Region (2019-2024)
    Table 19. Global Anti-Emetic Drug Sales by Region (2025-2030) & (K Units)
    Table 20. Global Anti-Emetic Drug Sales Market Share by Region (2025-2030)
    Table 21. Global Anti-Emetic Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Anti-Emetic Drug Revenue Market Share by Region (2019-2024)
    Table 23. Global Anti-Emetic Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Anti-Emetic Drug Revenue Market Share by Region (2025-2030)
    Table 25. North America Anti-Emetic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Anti-Emetic Drug Sales by Country (2019-2024) & (K Units)
    Table 27. North America Anti-Emetic Drug Sales by Country (2025-2030) & (K Units)
    Table 28. North America Anti-Emetic Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Anti-Emetic Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Anti-Emetic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Anti-Emetic Drug Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Anti-Emetic Drug Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Anti-Emetic Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Anti-Emetic Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Anti-Emetic Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Anti-Emetic Drug Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Anti-Emetic Drug Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Anti-Emetic Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Anti-Emetic Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Anti-Emetic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Anti-Emetic Drug Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Anti-Emetic Drug Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Anti-Emetic Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Anti-Emetic Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Anti-Emetic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Anti-Emetic Drug Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Anti-Emetic Drug Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Anti-Emetic Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Anti-Emetic Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Anti-Emetic Drug Sales (K Units) by Type (2019-2024)
    Table 51. Global Anti-Emetic Drug Sales (K Units) by Type (2025-2030)
    Table 52. Global Anti-Emetic Drug Sales Market Share by Type (2019-2024)
    Table 53. Global Anti-Emetic Drug Sales Market Share by Type (2025-2030)
    Table 54. Global Anti-Emetic Drug Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Anti-Emetic Drug Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Anti-Emetic Drug Revenue Market Share by Type (2019-2024)
    Table 57. Global Anti-Emetic Drug Revenue Market Share by Type (2025-2030)
    Table 58. Global Anti-Emetic Drug Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Anti-Emetic Drug Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Anti-Emetic Drug Sales (K Units) by Application (2019-2024)
    Table 61. Global Anti-Emetic Drug Sales (K Units) by Application (2025-2030)
    Table 62. Global Anti-Emetic Drug Sales Market Share by Application (2019-2024)
    Table 63. Global Anti-Emetic Drug Sales Market Share by Application (2025-2030)
    Table 64. Global Anti-Emetic Drug Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Anti-Emetic Drug Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Anti-Emetic Drug Revenue Market Share by Application (2019-2024)
    Table 67. Global Anti-Emetic Drug Revenue Market Share by Application (2025-2030)
    Table 68. Global Anti-Emetic Drug Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Anti-Emetic Drug Price (US$/Unit) by Application (2025-2030)
    Table 70. Merck Corporation Information
    Table 71. Merck Description and Business Overview
    Table 72. Merck Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Merck Anti-Emetic Drug Product
    Table 74. Merck Recent Developments/Updates
    Table 75. Novartis Corporation Information
    Table 76. Novartis Description and Business Overview
    Table 77. Novartis Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Novartis Anti-Emetic Drug Product
    Table 79. Novartis Recent Developments/Updates
    Table 80. Glenmark Pharmaceuticals Corporation Information
    Table 81. Glenmark Pharmaceuticals Description and Business Overview
    Table 82. Glenmark Pharmaceuticals Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Glenmark Pharmaceuticals Anti-Emetic Drug Product
    Table 84. Glenmark Pharmaceuticals Recent Developments/Updates
    Table 85. F. Hoffmann-La Roche Corporation Information
    Table 86. F. Hoffmann-La Roche Description and Business Overview
    Table 87. F. Hoffmann-La Roche Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. F. Hoffmann-La Roche Anti-Emetic Drug Product
    Table 89. F. Hoffmann-La Roche Recent Developments/Updates
    Table 90. Heron Therapeutics Corporation Information
    Table 91. Heron Therapeutics Description and Business Overview
    Table 92. Heron Therapeutics Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Heron Therapeutics Anti-Emetic Drug Product
    Table 94. Heron Therapeutics Recent Developments/Updates
    Table 95. Kyowa Kirin Corporation Information
    Table 96. Kyowa Kirin Description and Business Overview
    Table 97. Kyowa Kirin Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Kyowa Kirin Anti-Emetic Drug Product
    Table 99. Kyowa Kirin Recent Developments/Updates
    Table 100. Aurobindo Pharma Corporation Information
    Table 101. Aurobindo Pharma Description and Business Overview
    Table 102. Aurobindo Pharma Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Aurobindo Pharma Anti-Emetic Drug Product
    Table 104. Aurobindo Pharma Recent Developments/Updates
    Table 105. Mylan Corporation Information
    Table 106. Mylan Description and Business Overview
    Table 107. Mylan Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Mylan Anti-Emetic Drug Product
    Table 109. Mylan Recent Developments/Updates
    Table 110. Hikma Corporation Information
    Table 111. Hikma Description and Business Overview
    Table 112. Hikma Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Hikma Anti-Emetic Drug Product
    Table 114. Hikma Recent Developments/Updates
    Table 115. Akorn Corporation Information
    Table 116. Akorn Description and Business Overview
    Table 117. Akorn Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Akorn Anti-Emetic Drug Product
    Table 119. Akorn Recent Developments/Updates
    Table 120. Dr. Reddy’s Laboratories Corporation Information
    Table 121. Dr. Reddy’s Laboratories Description and Business Overview
    Table 122. Dr. Reddy’s Laboratories Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Dr. Reddy’s Laboratories Anti-Emetic Drug Product
    Table 124. Dr. Reddy’s Laboratories Recent Developments/Updates
    Table 125. Cipla Corporation Information
    Table 126. Cipla Description and Business Overview
    Table 127. Cipla Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Cipla Anti-Emetic Drug Product
    Table 129. Cipla Recent Developments/Updates
    Table 130. Fresenius Kabi Corporation Information
    Table 131. Fresenius Kabi Description and Business Overview
    Table 132. Fresenius Kabi Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Fresenius Kabi Anti-Emetic Drug Product
    Table 134. Fresenius Kabi Recent Developments/Updates
    Table 135. Wockhardt Corporation Information
    Table 136. Wockhardt Description and Business Overview
    Table 137. Wockhardt Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Wockhardt Anti-Emetic Drug Product
    Table 139. Wockhardt Recent Developments/Updates
    Table 140. Sun Pharmaceutical Industries Corporation Information
    Table 141. Sun Pharmaceutical Industries Description and Business Overview
    Table 142. Sun Pharmaceutical Industries Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Sun Pharmaceutical Industries Anti-Emetic Drug Product
    Table 144. Sun Pharmaceutical Industries Recent Developments/Updates
    Table 145. Teva Pharmaceutical Corporation Information
    Table 146. Teva Pharmaceutical Description and Business Overview
    Table 147. Teva Pharmaceutical Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 148. Teva Pharmaceutical Anti-Emetic Drug Product
    Table 149. Teva Pharmaceutical Recent Developments/Updates
    Table 150. Pfizer Corporation Information
    Table 151. Pfizer Description and Business Overview
    Table 152. Pfizer Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 153. Pfizer Anti-Emetic Drug Product
    Table 154. Pfizer Recent Developments/Updates
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Anti-Emetic Drug Distributors List
    Table 158. Anti-Emetic Drug Customers List
    Table 159. Anti-Emetic Drug Market Trends
    Table 160. Anti-Emetic Drug Market Drivers
    Table 161. Anti-Emetic Drug Market Challenges
    Table 162. Anti-Emetic Drug Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Anti-Emetic Drug
    Figure 2. Global Anti-Emetic Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Anti-Emetic Drug Market Share by Type in 2023 & 2030
    Figure 4. Oral Product Picture
    Figure 5. Injection Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Anti-Emetic Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Anti-Emetic Drug Market Share by Application in 2023 & 2030
    Figure 9. Hospital
    Figure 10. Clinic
    Figure 11. Home Care
    Figure 12. Others
    Figure 13. Global Anti-Emetic Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Anti-Emetic Drug Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Anti-Emetic Drug Sales (2019-2030) & (K Units)
    Figure 16. Global Anti-Emetic Drug Average Price (US$/Unit) & (2019-2030)
    Figure 17. Anti-Emetic Drug Report Years Considered
    Figure 18. Anti-Emetic Drug Sales Share by Manufacturers in 2023
    Figure 19. Global Anti-Emetic Drug Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Anti-Emetic Drug Players: Market Share by Revenue in 2023
    Figure 21. Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Anti-Emetic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Anti-Emetic Drug Sales Market Share by Country (2019-2030)
    Figure 24. North America Anti-Emetic Drug Revenue Market Share by Country (2019-2030)
    Figure 25. U.S. Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Anti-Emetic Drug Sales Market Share by Country (2019-2030)
    Figure 28. Europe Anti-Emetic Drug Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Anti-Emetic Drug Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Anti-Emetic Drug Revenue Market Share by Region (2019-2030)
    Figure 36. China Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Taiwan Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Philippines Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Anti-Emetic Drug Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Anti-Emetic Drug Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Anti-Emetic Drug Sales Market Share by Country (2019-2030)
    Figure 52. Middle East & Africa Anti-Emetic Drug Revenue Market Share by Country (2019-2030)
    Figure 53. Turkey Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. UAE Anti-Emetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Global Sales Market Share of Anti-Emetic Drug by Type (2019-2030)
    Figure 57. Global Revenue Market Share of Anti-Emetic Drug by Type (2019-2030)
    Figure 58. Global Anti-Emetic Drug Price (US$/Unit) by Type (2019-2030)
    Figure 59. Global Sales Market Share of Anti-Emetic Drug by Application (2019-2030)
    Figure 60. Global Revenue Market Share of Anti-Emetic Drug by Application (2019-2030)
    Figure 61. Global Anti-Emetic Drug Price (US$/Unit) by Application (2019-2030)
    Figure 62. Anti-Emetic Drug Value Chain
    Figure 63. Anti-Emetic Drug Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS